The effect of DPP-4 inhibitors on asthma control: an administrative database study to evaluate a potential pathophysiological relationship

Gene Colice1 Global Medicines Development, AstraZeneca, Gaithersburg, MD, USACorrespondence[email protected]

David Price2 Observational & Pragmatic Research Institute, Singapore;3 Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK

Maria Gerhardsson de Verdier4 Global Medical Affairs, AstraZeneca, Mölndal, Sweden

Karma Rabon-Stith5 Global Medical Affairs, AstraZeneca, Gaithersburg, MD, USA

Christopher Ambrose5 Global Medical Affairs, AstraZeneca, Gaithersburg, MD, USA

Katherine Cappell6 Custom Data Analytics, Life Sciences, Truven Health Analytics, an IBM Watson Health Company, Ann Arbor, MI, USA

Debra E Irwin7 Outcomes Research, Life Sciences, Truven Health Analytics, an IBM Watson Health Company, Bethesda, MD, USA

Paul Juneau7 Outcomes Research, Life Sciences, Truven Health Analytics, an IBM Watson Health Company, Bethesda, MD, USA

Anna Vlahiotis7 Outcomes Research, Life Sciences, Truven Health Analytics, an IBM Watson Health Company, Bethesda, MD, USA

Your download is now in progress and you may close this window